Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Crohn's Disease
Crohn's Disease
Abbott’s Freyman Says Humira Gained Market Share in Crohn’s, Psoriasis
Bloomberg
Wed, 07/20/11 - 12:50 pm
Crohn's Disease
psoriasis
Abbott Laboratories
Humira
Glenmark Sells Rights to New Drug to Sanofi
WSJ Online
Mon, 05/16/11 - 09:21 am
Glenmark
Sanofi
Crohn's Disease
GBR500
Crohn's patients respond to J&J's Stelara in study
Reuters
Mon, 05/9/11 - 09:22 am
JNJ
Stelara
Crohn's Disease
Basque consortium develops a microsensor monitoring arthritis and psoriasis
Fri, 07/9/10 - 01:42 pm
CIC microGUNE
BioDonostia Institute
Proteomika
Abyntek
Progenika Group
rheumatoid arthritis
Crohn's Disease
ulcerative colitis or psoriasis
REMICADE(R) Study Results Show Greater Steroid-Free Remission and Mucosal Healing Compared With Conventional Immunomodulator Azathioprine in Treatment of Crohn's Disease
PR Newswire
Thu, 04/15/10 - 10:12 am
Remicade
Crohn's Disease
JNJ
Celgene says stem cell therapy met safety goal
Yahoo/AP
Fri, 04/9/10 - 11:27 am
Celgene
stem cells
Crohn's Disease
FDA and Clinical Trial Updates: Osiris Sees Flaw in Crohn's Disease Trial
Seeking Alpha
Sun, 03/29/09 - 10:50 am
FDA
drug trials
Osiris Therapeutics
Crohn's Disease
Roche
Spectrum Pharmaceuticals
Dyax
Osiris, Genzyme discontinue Phase III trial
Marketwatch
Fri, 03/27/09 - 07:50 am
drug trials
Osiris Therapeutics
Genzyme
Prochymal
Crohn's Disease
Pages
« first
‹ previous
1
2
3
4
5